Filtros : "Instituto Butantan (IB)" "Ishii, Marina" "FCF" Removidos: "IQ002" "Rangel-Yagui, Carlota de Oliveira" "China" "França" Limpar

Filtros



Limitar por data


  • Fonte: MedChemComm. Unidade: FCF

    Assuntos: TRYPANOSOMA CRUZI, ANTIPARASITÁRIOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JORGE, Salomão Dória et al. Preliminary in vitro evaluation of N'-(benzofuroxan-5-yl)methylene benzohydrazide derivatives as potential anti-Trypanosoma cruzi agents. MedChemComm, v. 3, n. 7, p. 824-828 : + Supplementary materials ( S1-S11), 2012Tradução . . Disponível em: https://doi.org/10.1039/c2md20019h. Acesso em: 02 out. 2024.
    • APA

      Jorge, S. D., Ishii, M., Palace-Berl, F., Ferreira, A. K., Sá Júnior, P. L. de, Oliveira, A. A. de, et al. (2012). Preliminary in vitro evaluation of N'-(benzofuroxan-5-yl)methylene benzohydrazide derivatives as potential anti-Trypanosoma cruzi agents. MedChemComm, 3( 7), 824-828 : + Supplementary materials ( S1-S11). doi:10.1039/c2md20019h
    • NLM

      Jorge SD, Ishii M, Palace-Berl F, Ferreira AK, Sá Júnior PL de, Oliveira AA de, Sonehara IY, Pasqualoto KFM, Tavares LC. Preliminary in vitro evaluation of N'-(benzofuroxan-5-yl)methylene benzohydrazide derivatives as potential anti-Trypanosoma cruzi agents [Internet]. MedChemComm. 2012 ; 3( 7): 824-828 : + Supplementary materials ( S1-S11).[citado 2024 out. 02 ] Available from: https://doi.org/10.1039/c2md20019h
    • Vancouver

      Jorge SD, Ishii M, Palace-Berl F, Ferreira AK, Sá Júnior PL de, Oliveira AA de, Sonehara IY, Pasqualoto KFM, Tavares LC. Preliminary in vitro evaluation of N'-(benzofuroxan-5-yl)methylene benzohydrazide derivatives as potential anti-Trypanosoma cruzi agents [Internet]. MedChemComm. 2012 ; 3( 7): 824-828 : + Supplementary materials ( S1-S11).[citado 2024 out. 02 ] Available from: https://doi.org/10.1039/c2md20019h

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024